Latest Content

10 of 2252 Shown
  • HIV and Cardiovascular Disease: How Worried Should We Be?

    In this downloadable slideset, David A. Wohl, MD, reviews the association between HIV and cardiovascular disease, including potential contributing factors and best practices in prevention.
    Date Posted: 6/26/2015
  • Special Populations and Areas of Unmet Need in HCV Infection

    In this downloadable slideset, Paul Y. Kwo, MD, reviews strategies for managing HCV infection in challenging patient populations, including an overview of data on the safety and efficacy of current regimens as well as potential future options.
    Date Posted: 6/25/2015
  • Best Practices in the Management of HCV in 2015

    In this downloadable slideset, Andrew J. Muir, MD, reviews the evidence informing current guidance and best practices on treating patients with hepatitis C.
    Date Posted: 6/19/2015
  • Shifting Roles for Single-Tablet Regimens in the Latest DHHS Guidelines

    Karam Mounzer MD - 6/16/2015
    I explain how the concept of “net potency” plays a key role when considering the use of single-tablet regimens as first-line therapy.
  • ART Update 2015

    In this downloadable slideset, Joel E. Gallant, MD, MPH, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at upcoming agents currently under investigation.
    Date Posted: 6/15/2015
  • How I Implement Shared Decision Making When Selecting First-line ART

    Kevin M. O'Hara MMSc, MS, PA-C - 6/12/2015
    I review my patient-centered approach to choosing the right regimen as initial therapy.
  • Video Module cme-icon ce-icon

    Integrating Recent Data When Selecting First-line Antiretroviral Therapy

    Watch as HIV experts, Joseph J. Eron, Jr., MD; W. David Hardy, MD; and Paul E. Sax, MD, discuss their approach to selecting first-line antiretroviral therapy for HIV-infected patients.
    Faculty: Joseph J. Eron, Jr. MD, W. David Hardy MD, Paul E. Sax MD
    Released: 6/10/2015
  • Integrating Recent Data When Selecting First-line Antiretroviral Therapy

    Use this downloadable slideset as a companion guide to the short video module in which HIV experts, Joseph J. Eron, Jr., MD; W. David Hardy, MD; and Paul E. Sax, MD, discuss their approach to selecting first-line antiretroviral therapy for HIV-infected patients.
    Date Posted: 6/10/2015
  • Strategic ART Switching: If It’s Not Broken, Should We Still Fix It?

    David A. Wohl MD - 5/27/2015 3 comments / Last Comment: 6/21/2015
    How do the DHHS guidelines and recent switch studies affect our decision to change regimens in virologically suppressed patients?
  • Will Healthcare Reform Challenge Our Ability to Prescribe Single-Tablet Regimens?

    William G. Powderly MD - 5/18/2015 1 comment / Last Comment: 6/15/2015
    I recently encountered an unexpected challenge in my clinic after prescribing a single-tablet regimen for a newly diagnosed HIV-infected patient.
10 of 2252 Shown
Show 10 More
Loading...  
Decision Support
Free
inPractice
Immediate answers to treatment questions
More than just up to date